Molecular Imaging: Page 14

New PET tracer improves detection of insulinomas

By Will Morton

A new PET/CT radiotracer that detects insulinomas could eliminate the need for other diagnostic procedures in a vast majority of patients.

October 21, 2024

Tc-99m shortage expected into November

By Will Morton

The delayed restart of a nuclear research reactor in the Netherlands is expected to cause supply shortages of technetium-99m (Tc-99m) into November.

October 18, 2024

FAPI-PET shows value in staging lung cancer patients

By Will Morton

Fibroblast activation protein inhibitor (FAPI) PET/CT shows excellent diagnostic accuracy for detecting lymph node metastases in lung cancer patients

October 17, 2024

New guidelines cover theranostics for brain tumors

By Will Morton

The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise.

October 14, 2024

NNSA's Mo-99 program: A bumpy ride

By Will Morton

Last year was a bumpy ride for a U.S. initiative to secure domestic supplies of molybdenum-99 (Mo-99).

October 10, 2024

FES-PET improves management of breast cancer patients

By Will Morton

PET/CT imaging with F-18 fluroestradiol (FES) can play a significant role in helping clinicians make treatment decisions in patients with recurrent or metastatic breast cancer

October 7, 2024

What impact will flurpiridaz F-18 have on heart care?

By Will Morton

Seventeen years was all it took for flurpiridaz F-18 to reach the market, with the first patient injected with the PET imaging agent in November, 2007.

October 4, 2024

PET identifies risk of metastases in patients with HNSCC

By Will Morton

PET imaging with F-18 fluoromisonidazole can determine whether cancer may spread in patients undergoing chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC).

October 1, 2024

Nuclear cardiology could face cuts in 2025

By Will Morton

Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert.

September 25, 2024

How effective is Pluvicto in a ‘real-world’ setting?

By Will Morton

Pluvicto appears to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval.

September 20, 2024

Microplastics reach the olfactory bulb in the human brain

By Will Morton

Pathologists have detected microplastics in olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, Brazil.

September 19, 2024

NYC researchers propose criteria for FMISO-PET imaging

By Will Morton

Proposed criteria for F-18 fluoromisonidazole (FMISO) PET imaging can help clinicians manage patients with head and neck cancer.

September 17, 2024

Previous Page

Page 14 of 610

Next Page